Skip to content
Home/ Discovery and Development of New Liver Cancer Stem Cell Inhibitor
Discovery and Development of New Liver Cancer Stem Cell Inhibitor

Discovery and Development of New Liver Cancer Stem Cell Inhibitor

No customer reviews yet ISBN 9786208170325

This study examined the possibility of using innovative isoxazole derivatives as agents for treating liver cancer, combining several computational methods. A reliable model (QSAR) was used to identify six compounds (Pr1-Pr6) with high anticancer activity compared to that of the anticancer drug SORAFENIB (SOR). The Lipinski characteristics and synthetic accessibility coefficient of the newly developed compounds suggest their potential for therapeutic use. Candidate Pr3 has a stronger binding affinity with the target receptors (PDB ID: 1QX3 and 2AR9) compared to the other compounds. The study of the transport of candidates through the tunnels linking the active site and the receptor surface allows their biological efficiencies to be compared. Computer-aided retrosynthesis enabled us to propose highly reliable sequences for the synthesis of the proposed drug candidates. The results provide valuable information on the potential use of these compounds for the treatment of liver cancer.

About the author

Product details

Pub dateDec 24, 2025
ISBN-10620817032X
ISBN-139786208170325
LanguageEnglish
Last updated 2026-08-24 06:13
$47.43 $51.00 7% off
You save $3.57 · list price $51.00
In stock — ships in 24 hours with free tracking
Delivery by Friday, October 2, 2026
Qty
Sign in to Add to Saved list
Free delivery on orders over $35.
15-day returns. Any reason.
Secure checkout. We never store card details.

Readers who bought this also bought

More from Life Sciences - Biochemistry
See all
RNA
Söll, D
$427.37